Final Report Summary - OPENLABCAMPUS (Neglected Diseases Tres Cantos Open Lab Campus) The Tres Cantos Open Lab Foundation (TCOLF) is committed to helping transform the process of drug discovery for infectious diseases impacting the developing world. We believe that no single entity can succeed alone in the worldwide fight against these diseases. The Tres Cantos Open Lab Foundation was established on the principles of open innovation and collaboration to enable researchers to work in an open environment where the wider sharing of ideas and findings drives collaborative innovation.Open Lab projects explore new ideas that may lead to finding new medicines to treat, control or prevent infectious diseases impacting the developing world, especially tuberculosis, malaria, Chagas, leishmaniasis and, more recently, gut health. To be considered for support, there should be added value for the project in operating within the collaborative principles of the Open Lab.The TCOLF Cofund programme has supported 11 scientists to develop their ideas in the field and to accelerate the translation of targets, molecules or drug discovery tools into viable medicines, accessing GSK drug discovery expertise and working during all or part of their fellowship at its research facilities in Spain.Since March 2013, we invited interested researchers to submit applications to seven Cofund calls, subject to the published eligibility criteria. We received 52 proposals in response to such calls. Eligible proposals were evaluated by the TCOLF Governing Board members and 13 of them were selected for funding (2 fellows rejected their fellowship after the award).A description of these projects, the fellows involved and their supporting institutions is published in the TCOLF website (http://www.openlabfoundation.org).
